About this trial
The goal of the DC Cohort is to establish a clinic-based city-wide longitudinal cohort that will describe clinical outcomes, and improve the quality of care for patients diagnosed with Human Immunodeficiency Virus/Acquired Immune Deficiency Syndrome (HIV/AIDS) or at higher risk for acquiring HIV and receiving care in Washington, DC.
Eligibility criteria
Qualifiers
Patient is receiving care for HIV at one or more of the twelve participating clinics in the DC Cohort.
Patient is either age 18 years or older, or seeks HIV care independently and is able to understand and sign informed consent.
Patient is a minor who is consented by a parent or legal guardian.
Disqualifiers
Patient is unable or refuses to provide informed consent.
Minor children ages 12 through 17 who are unaware of their HIV status
PrEP (e.g., TDF/FTC, Descovy, Apretude)
Combination ART indicative of nPEP in an HIV-uninfected person
Trial design
Treatments tested in this trial
- Not listed
Trial groups
Sponsors and collaborators
George Washington University
Lead sponsor
National Institute of Allergy and Infectious Diseases (NIAID)
Collaborator